NEW YORK CITY, NY / ACCESS Newswire / August 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation ("Neogen" or the "Company") (NASDAQ:NEOG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Neogen and certain of its officers and/or directors […]
NEW YORK, NY / ACCESS Newswire / August 3, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against XPLR Infrastructure, LP ("XPLR" or the "Company") (NYSE:XIFR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
NEW YORK CITY, NY / ACCESS Newswire / August 3, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Tempus AI, Inc.â?¯("Tempus" or the "Company") (NASDAQ:TEM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comâ?¯or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to
NEW YORK CITY, NY / ACCESS Newswire / August 3, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Apple Inc. ("Apple" or the "Company") (NASDAQ:AAPL) and certain officers.�� The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-05197, is
NEW YORK CITY, NY / ACCESS Newswire / August 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ:NEO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether NeoGenomics and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / August 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of KBR, Inc. ("KBR" or the "Company") (NYSE:KBR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether KBR and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / August 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Jasper Therapeutics, Inc. ("Jasper" or the "Company") (NASDAQ:JSPR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Jasper and certain of its officers and/or
NEW YORK, NY / ACCESS Newswire / August 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Funko, Inc. ("Funko" or the "Company") (NASDAQ:FNKO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Funko and certain of its officers and/or directors have
NEW YORK CITY, NY / ACCESS Newswire / August 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Ultragenyx Pharmaceutical Inc. ("Ultragenyx" or the "Company") (NASDAQ:RARE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Ultragenyx and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / August 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Simulations Plus, Inc. ("Simulations Plus" or the "Company") (NASDAQ:SLP). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Simulations Plus and certain of its